Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Genetics

Your Medical Roadmap: A Lifelong Surveillance Plan

At a Glance

People with Gorlin syndrome need a lifelong medical surveillance plan tailored to their specific gene mutation (PTCH1 or SUFU). Key screenings include early childhood brain MRIs, routine dental X-rays starting at age 8, lifelong skin exams, and strict sun protection.

Because Gorlin syndrome is a multisystem condition, the key to staying healthy is a specialized surveillance plan. Think of this plan as a “medical roadmap” that changes as you or your child grows. The most important factor in your roadmap is whether the mutation is in the PTCH1 gene or the SUFU gene, as these two types require different screening priorities [1][2].

The Surveillance Roadmap by Age

Infants and Young Children (Ages 0–5)

The primary focus during these years is the early detection of rare but treatable tumors [3].

  • SUFU Mutation: Children with a SUFU mutation need aggressive brain monitoring. Current consensus recommends a brain MRI every 4 months from birth until age 5 to screen for medulloblastoma [1][2].
  • PTCH1 Mutation: The risk of medulloblastoma is much lower (less than 2%), so brain MRIs may be performed less frequently or only as a baseline, depending on your doctor’s recommendation [4][1].
  • Heart Health: A baseline echocardiogram (heart ultrasound) is often recommended at birth to check for cardiac fibromas, which are non-cancerous heart tumors that are usually present from birth if they occur at all [3][5].

Childhood and Adolescence (Ages 5–18)

As children grow, the focus shifts to the jaw and skin [6][7].

  • Dental Checks: For PTCH1 carriers, annual panoramic X-rays (orthopantograms) should typically begin around age 8 to look for “silent” jaw cysts (OKCs) [1]. SUFU carriers have a much lower risk for these cysts but still need regular dental exams [1][8].
  • Skin Exams: Full-body skin checks by a dermatologist should begin by age 10 for PTCH1 carriers [1][6].
  • Ovarian Health: For females, a baseline pelvic ultrasound is recommended in late childhood or early adolescence to screen for ovarian fibromas [9][10].
  • Spinal Health: A baseline spinal X-ray may be considered in childhood to check for scoliosis or unusual rib formations, as these are common minor criteria [11].

Adulthood (Ages 18+)

In adulthood, management focuses on long-term skin health and monitoring for any recurrences [12][6].

  • Skin: Professional skin checks every 6 to 12 months, or more often if many BCCs are present [12].
  • Jaw: Continued dental X-rays every 1–2 years, as new cysts can form even in adulthood [13][14].

Lifetime Priorities for Everyone

Regardless of your specific gene mutation, these critical rules apply to every person with Gorlin syndrome:

  1. Strict Sun Protection: UV exposure is the primary trigger for the growth of Basal Cell Carcinomas [12][15]. Lifelong use of high-SPF sunscreen, wide-brimmed hats, and UV-protective clothing is the single most effective way to reduce the number of surgeries you will need over your lifetime [16][15]. Practical steps like applying UV-protective window film to your car can also be highly beneficial.
  2. Monitor Vitamin D: Because you are rigorously avoiding the sun, you are at a very high risk for Vitamin D deficiency. Talk to your doctor about checking your Vitamin D levels regularly and taking daily supplements to protect your bone health and mood [12].
  3. Avoid Radiation: You must avoid therapeutic radiation (such as X-ray treatments for skin lesions) because it can cause an explosion of new tumors [17][18]. Diagnostic X-rays (like dental or chest X-rays) are safe but should be kept to the minimum necessary for screening [1].
Screening Type PTCH1 Carrier SUFU Carrier
Brain MRI Baseline / as needed [1] Every 4 months to age 5 [1]
Skin Exam Every 6-12 months [1] Every 6-12 months [1]
Jaw X-ray Annually from age 8 [1] Less frequent / as needed [8]
Pelvic Ultrasound Once in adolescence [9] Once in adolescence [9]

By following this roadmap, you can detect issues early when they are easiest to treat, ensuring the best possible long-term health [12][19].

Common questions in this guide

How often should a child with Gorlin syndrome have a brain MRI?
Children with a SUFU mutation need a brain MRI every four months from birth until age five to screen for medulloblastoma. For those with a PTCH1 mutation, MRIs may be performed less frequently or only as a baseline based on a doctor's recommendation.
When should dental X-rays start for Gorlin syndrome?
Annual panoramic dental X-rays should typically begin around age 8 for children with a PTCH1 mutation to look for silent jaw cysts. Those with a SUFU mutation have a lower risk but still require regular dental exams.
Why do people with Gorlin syndrome need Vitamin D supplements?
Because individuals with Gorlin syndrome must strictly avoid sun exposure to prevent basal cell carcinomas, they are at a high risk for Vitamin D deficiency. Daily supplements are often recommended to protect bone health and mood.
Are X-rays safe for someone with Gorlin syndrome?
Diagnostic X-rays, such as dental or chest X-rays, are safe but should be kept to the minimum necessary for screening. However, therapeutic radiation used to treat skin lesions must be avoided because it can trigger a rapid growth of new tumors.
At what age should regular pelvic ultrasounds begin to screen for ovarian fibromas?
A baseline pelvic ultrasound is recommended for females in late childhood or early adolescence to screen for ovarian fibromas.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on our genetic results (PTCH1 or SUFU), exactly how often should we be doing brain MRIs, and when can we stop?
  2. 2.When should my child have their first baseline panoramic dental X-ray?
  3. 3.Is it necessary to perform a baseline heart ultrasound (echocardiogram) to check for cardiac fibromas?
  4. 4.At what age should we begin regular pelvic ultrasounds to screen for ovarian fibromas?
  5. 5.Because I am avoiding the sun, should I have my Vitamin D levels checked today?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).

    Guerrini-Rousseau L, Smith MJ, Kratz CP, et al.

    Familial cancer 2021; (20(4)):317-325 doi:10.1007/s10689-021-00247-z.

    PMID: 33860896
  2. 2

    Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.

    Foulkes WD, Kamihara J, Evans DGR, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2017; (23(12)):e62-e67 doi:10.1158/1078-0432.CCR-17-0595.

    PMID: 28620006
  3. 3

    Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome.

    Ritter AL, Granquist EJ, Iyer VR, Izumi K

    Molecular syndromology 2018; (9(4)):219-223 doi:10.1159/000489056.

    PMID: 30140199
  4. 4

    Gorlin-like phenotype in a patient with a PTCH2 variant of uncertain significance.

    Casano K, Meddaugh H, Zambrano RM, et al.

    European journal of medical genetics 2020; (63(4)):103842 doi:10.1016/j.ejmg.2020.103842.

    PMID: 31945512
  5. 5

    Cardiac Fibroma with Asymptomatic Ventricular Arrhythmia in an Adolescent with Gorlin's Syndrome.

    Menon D, Dentel JN, Sanil Y, Lawrence D

    Journal of pediatric genetics 2023; (12(2)):171-174 doi:10.1055/s-0040-1722287.

    PMID: 37090839
  6. 6

    Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.

    Hasan Ali O, Yurchenko AA, Pavlova O, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(2)):396-402 doi:10.1111/jdv.16767.

    PMID: 32564428
  7. 7

    Clinical, radiographic, pathological and inherited characteristics of odontogenic keratocyst in nevoid basal cell carcinoma syndrome: a study in three Chilean families.

    Castillo-Tobar A, Urzúa B, Tirreau V, et al.

    Oral radiology 2023; (39(3)):518-527 doi:10.1007/s11282-022-00664-5.

    PMID: 36436193
  8. 8

    Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.

    Guerrini-Rousseau L, Dufour C, Varlet P, et al.

    Neuro-oncology 2018; (20(8)):1122-1132 doi:10.1093/neuonc/nox228.

    PMID: 29186568
  9. 9

    Bilateral ovarian fibromas as the sole manifestation of Gorlin syndrome in a 22-year-old woman: a case report and literature review.

    Zhu M, Li J, Duan J, et al.

    Diagnostic pathology 2023; (18(1)):118 doi:10.1186/s13000-023-01406-9.

    PMID: 37907964
  10. 10

    Advanced basal cell carcinoma: What dermatologists need to know about diagnosis.

    Krakowski AC, Hafeez F, Westheim A, et al.

    Journal of the American Academy of Dermatology 2022; (86(6S)):S1-S13 doi:10.1016/j.jaad.2022.03.023.

    PMID: 35577405
  11. 11

    Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome.

    Mochizuki AY, Nagaraj CB, Depoorter D, et al.

    American journal of medical genetics. Part A 2024; (194(10)):e63788 doi:10.1002/ajmg.a.63788.

    PMID: 38864234
  12. 12

    A Rare Case of Gorlin-Goltz Syndrome in Children.

    Boos Lima FBDJ, Viana APC, Lima LHF, et al.

    Case reports in dentistry 2019; (2019()):1608783 doi:10.1155/2019/1608783.

    PMID: 31934460
  13. 13

    Clinical profile and prevalence of odontogenic keratocysts in children and adolescents: A systematic review.

    Cunha JDS, Severino-Lazo R, Felipe Junior J, et al.

    Journal of oral biology and craniofacial research 2026; (16(2)):101414 doi:10.1016/j.jobcr.2026.101414.

    PMID: 41704402
  14. 14

    Nevoid Basal Cell Carcinoma Syndrome: A Long-Term Study in a Family.

    de Santana Santos T, Vajgel A, Martins-Filho PR, et al.

    Craniomaxillofacial trauma & reconstruction 2016; (9(1)):94-104 doi:10.1055/s-0035-1558454.

    PMID: 26889355
  15. 15

    Nevoid Basal Cell Carcinoma Syndrome - Clinical and Radiological Findings of Three Cases.

    Ali IK, Karjodkar FR, Sansare K, et al.

    Cureus 2016; (8(8)):e727 doi:10.7759/cureus.727.

    PMID: 27630800
  16. 16

    BASAL CELL NEVUS SYNDROME PRESENTING AS EPIRETINAL MEMBRANE AND MYELINATED NERVE FIBER LAYER.

    Farley ND, Sassalos TM, Ober MD

    Retinal cases & brief reports 2017; (11 Suppl 1()):S151-S154 doi:10.1097/ICB.0000000000000388.

    PMID: 27533646
  17. 17

    Severe PATCHED1 Deficiency in Cancer-Prone Gorlin Patient Cells Results in Intrinsic Radiosensitivity.

    Vulin A, Sedkaoui M, Moratille S, et al.

    International journal of radiation oncology, biology, physics 2018; (102(2)):417-425 doi:10.1016/j.ijrobp.2018.05.057.

    PMID: 30191873
  18. 18

    Basal cell nevus syndrome: From DNA to therapeutics.

    Lin MJ, Dubin DP, Khorasani H, Giordano CN

    Clinics in dermatology 2020; (38(4)):467-476 doi:10.1016/j.clindermatol.2020.03.003.

    PMID: 32972605
  19. 19

    Genetic aspects of Gorlin‒Goltz syndrome

    Vetró É, Oláh J, Nagy D, et al.

    Orvosi hetilap 2020; (161(49)):2072-2077 doi:10.1556/650.2020.31933.

    PMID: 33279882

This page explains general surveillance guidelines for Gorlin syndrome for educational purposes only. Always consult your geneticist or care coordinator to determine the best screening schedule for your specific gene mutation.

Get notified when new evidence is published on Gorlin syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.